Incretins

DRUG3 trials

Sponsors

University of Campania Luigi Vanvitelli, Rijnstate Ziekenhuis

Conditions

Coronary ArteriosclerosisCoronary Artery DiseaseCoronary SyndromeDiabetesGastric emptying hormonal changesSTEMI

Phase 4

Epicardial Fat and Clinical Outcomes After Coronary Artery Bypass Grafting in Diabetics vs. Non Diabetics

CompletedNCT03360981

University of Campania Luigi VanvitelliCoronary Artery Disease, Diabetes

Start: 2017-09-20End: 2025-08-20Updated: 2026-04-23

Unknown Phase

STEMI and Incretins Treatment

CompletedNCT03312179

University of Campania Luigi VanvitelliCoronary Arteriosclerosis, Coronary Artery Disease, Coronary Syndrome +2

Start: 2017-01-01End: 2017-10-01Updated: 2017-10-19

Bariatric procedures and changes in gut hormones and gastric passage

Active, not recruitingNL-OMON44151

Rijnstate ZiekenhuisGastric emptying hormonal changes

Start: 2018-10-09Target: 15Updated: 2024-02-28

Related Papers

Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: effects of metformin.

2019-09-3073 citations

Effects of incretin treatment on cardiovascular outcomes in diabetic STEMI-patients with culprit obstructive and multivessel non obstructive-coronary-stenosis.

2018-01-0366 citations